Literature DB >> 31551537

BH3-only proteins target BCL-xL/MCL-1, not BAX/BAK, to initiate apoptosis.

Kai Huang1,2, Katelyn L O'Neill1, Jian Li1,2, Wei Zhou1,3, Na Han1,4, Xiaming Pang1, Wei Wu1,5, Lucas Struble1, Gloria Borgstahl1, Zhaorui Liu1,6, Liqiang Zhang1, Xu Luo7,8.   

Abstract

It has been widely accepted that mitochondria-dependent apoptosis initiates when select BH3-only proteins (BID, BIM, etc.) directly engage and allosterically activate effector proteins BAX/BAK. Here, through reconstitution of cells lacking all eight pro-apoptotic BH3-only proteins, we demonstrate that all BH3-only proteins primarily target the anti-apoptotic BCL-2 proteins BCL-xL/MCL-1, whose simultaneous suppression enables membrane-mediated spontaneous activation of BAX/BAK. BH3-only proteins' apoptotic activities correlate with affinities for BCL-xL/MCL-1 instead of abilities to directly activate BAX/BAK. Further, BID and BIM do not distinguish BAX from BAK or accelerate BAX/BAK activation following inactivation of BCL-xL/MCL-1. Remarkably, death ligand-induced apoptosis in cells lacking BH3-only proteins and MCL-1 is fully restored by BID mutants capable of neutralizing BCL-xL, but not direct activation of BAX/BAK. Taken together, our findings provide a "Membrane-mediated Permissive" model, in which the BH3-only proteins only indirectly activate BAX/BAK by neutralizing the anti-apoptotic BCL-2 proteins, and thus allowing BAX/BAK to undergo unimpeded, spontaneous activation in the mitochondrial outer membrane milieu, leading to apoptosis initiation.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31551537      PMCID: PMC6888900          DOI: 10.1038/s41422-019-0231-y

Source DB:  PubMed          Journal:  Cell Res        ISSN: 1001-0602            Impact factor:   25.617


  45 in total

1.  Hierarchical regulation of mitochondrion-dependent apoptosis by BCL-2 subfamilies.

Authors:  Hyungjin Kim; Mubina Rafiuddin-Shah; Ho-Chou Tu; John R Jeffers; Gerard P Zambetti; James J-D Hsieh; Emily H-Y Cheng
Journal:  Nat Cell Biol       Date:  2006-11-19       Impact factor: 28.824

2.  Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics.

Authors:  Anthony Letai; Michael C Bassik; Loren D Walensky; Mia D Sorcinelli; Solly Weiler; Stanley J Korsmeyer
Journal:  Cancer Cell       Date:  2002-09       Impact factor: 31.743

Review 3.  The BCL-2 protein family: opposing activities that mediate cell death.

Authors:  Richard J Youle; Andreas Strasser
Journal:  Nat Rev Mol Cell Biol       Date:  2008-01       Impact factor: 94.444

Review 4.  How do BCL-2 proteins induce mitochondrial outer membrane permeabilization?

Authors:  Jerry E Chipuk; Douglas R Green
Journal:  Trends Cell Biol       Date:  2008-03-07       Impact factor: 20.808

5.  Membrane binding by tBid initiates an ordered series of events culminating in membrane permeabilization by Bax.

Authors:  Jonathan F Lovell; Lieven P Billen; Scott Bindner; Aisha Shamas-Din; Cecile Fradin; Brian Leber; David W Andrews
Journal:  Cell       Date:  2008-12-12       Impact factor: 41.582

6.  Bax crystal structures reveal how BH3 domains activate Bax and nucleate its oligomerization to induce apoptosis.

Authors:  Peter E Czabotar; Dana Westphal; Grant Dewson; Stephen Ma; Colin Hockings; W Douglas Fairlie; Erinna F Lee; Shenggen Yao; Adeline Y Robin; Brian J Smith; David C S Huang; Ruth M Kluck; Jerry M Adams; Peter M Colman
Journal:  Cell       Date:  2013-01-31       Impact factor: 41.582

Review 7.  The BCL-2 arbiters of apoptosis and their growing role as cancer targets.

Authors:  Jerry M Adams; Suzanne Cory
Journal:  Cell Death Differ       Date:  2017-11-03       Impact factor: 15.828

Review 8.  Cytochrome C-mediated apoptosis.

Authors:  Xuejun Jiang; Xiaodong Wang
Journal:  Annu Rev Biochem       Date:  2004       Impact factor: 23.643

9.  Stepwise activation of BAX and BAK by tBID, BIM, and PUMA initiates mitochondrial apoptosis.

Authors:  Hyungjin Kim; Ho-Chou Tu; Decheng Ren; Osamu Takeuchi; John R Jeffers; Gerard P Zambetti; James J-D Hsieh; Emily H-Y Cheng
Journal:  Mol Cell       Date:  2009-11-13       Impact factor: 17.970

10.  BAX activation is initiated at a novel interaction site.

Authors:  Evripidis Gavathiotis; Motoshi Suzuki; Marguerite L Davis; Kenneth Pitter; Gregory H Bird; Samuel G Katz; Ho-Chou Tu; Hyungjin Kim; Emily H-Y Cheng; Nico Tjandra; Loren D Walensky
Journal:  Nature       Date:  2008-10-23       Impact factor: 49.962

View more
  23 in total

1.  Noxa and Mcl-1 expression influence the sensitivity to BH3-mimetics that target Bcl-xL in patient-derived glioma stem cells.

Authors:  Mariana Belén Vera; Olivia Morris-Hanon; Germán Ignacio Nogueiras; Luisina Belén Ripari; Myrian Inés Esquivel; Carolina Perez-Castro; Leonardo Romorini; Gustavo Emilio Sevlever; María Elida Scassa; Guillermo Agustín Videla-Richardson
Journal:  Sci Rep       Date:  2022-10-22       Impact factor: 4.996

2.  Ancient and conserved functional interplay between Bcl-2 family proteins in the mitochondrial pathway of apoptosis.

Authors:  Nikolay Popgeorgiev; Jaison D Sa; Lea Jabbour; Suresh Banjara; Trang Thi Minh Nguyen; Aida Akhavan-E-Sabet; Rudy Gadet; Nikola Ralchev; Stéphen Manon; Mark G Hinds; Hans-Jürgen Osigus; Bernd Schierwater; Patrick O Humbert; Ruth Rimokh; Germain Gillet; Marc Kvansakul
Journal:  Sci Adv       Date:  2020-09-30       Impact factor: 14.136

Review 3.  Small molecules in targeted cancer therapy: advances, challenges, and future perspectives.

Authors:  Lei Zhong; Yueshan Li; Liang Xiong; Wenjing Wang; Ming Wu; Ting Yuan; Wei Yang; Chenyu Tian; Zhuang Miao; Tianqi Wang; Shengyong Yang
Journal:  Signal Transduct Target Ther       Date:  2021-05-31

4.  The BCL-2 inhibitor ABT-199/venetoclax synergizes with proteasome inhibition via transactivation of the MCL-1 antagonist NOXA.

Authors:  Hans-Georg Kopp; Frank Essmann; Sandra Weller; Astrid Toennießen; Benjamin Schaefer; Tobias Beigl; Alina Muenchow; Kathrin Böpple; Ute Hofmann; Bernhard F Gillissen; Walter E Aulitzky
Journal:  Cell Death Discov       Date:  2022-04-20

5.  miR-346 Inhibited Apoptosis Against Myocardial Ischemia-Reperfusion Injury via Targeting Bax in Rats.

Authors:  Xiangwei Lv; Pan Lu; Yisen Hu; Tongtong Xu
Journal:  Drug Des Devel Ther       Date:  2020-02-27       Impact factor: 4.162

Review 6.  Mitochondrial Bioenergetics and Turnover during Chronic Muscle Disuse.

Authors:  Jonathan M Memme; Mikhaela Slavin; Neushaw Moradi; David A Hood
Journal:  Int J Mol Sci       Date:  2021-05-13       Impact factor: 5.923

Review 7.  The Bcl-2 Family: Ancient Origins, Conserved Structures, and Divergent Mechanisms.

Authors:  Suresh Banjara; Chathura D Suraweera; Mark G Hinds; Marc Kvansakul
Journal:  Biomolecules       Date:  2020-01-12

8.  Conformational Switching in Bcl-xL: Enabling Non-Canonic Inhibition of Apoptosis Involves Multiple Intermediates and Lipid Interactions.

Authors:  Victor Vasquez-Montes; Alexander Kyrychenko; Mauricio Vargas-Uribe; Mykola V Rodnin; Alexey S Ladokhin
Journal:  Cells       Date:  2020-02-26       Impact factor: 6.600

9.  Glucocorticoids can induce BIM to trigger apoptosis in the absence of BAX and BAK1.

Authors:  Li Dong; David L Vaux
Journal:  Cell Death Dis       Date:  2020-06-08       Impact factor: 8.469

Review 10.  Reconstituting the Mammalian Apoptotic Switch in Yeast.

Authors:  Peter Polčic; Marek Mentel
Journal:  Genes (Basel)       Date:  2020-01-29       Impact factor: 4.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.